Top 10 Doxazosin (Cardura) Generic Manufacturers in Israel

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Israel has been experiencing steady growth in recent years, with a focus on the production of generic drugs such as Doxazosin (Cardura). With the increasing demand for cost-effective medications, many manufacturers in Israel have been ramping up their production of Doxazosin generics. According to recent data, the global market for generic drugs is expected to reach $380 billion by 2025.

Top 10 Doxazosin (Cardura) Generic Manufacturers in Israel:

1. Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. is the largest generic drug manufacturer in Israel, with a production volume of over 100,000 units of Doxazosin per year. The company holds a significant market share in the country and exports its products to various markets worldwide.

2. Perrigo Israel Pharmaceuticals Ltd.
Perrigo Israel Pharmaceuticals Ltd. is another key player in the Israeli pharmaceutical industry, specializing in the production of generic medications, including Doxazosin. The company’s Doxazosin products are known for their high quality and competitive pricing, making them popular among consumers.

3. Mylan Laboratories Ltd.
Mylan Laboratories Ltd. is a leading manufacturer of generic drugs in Israel, with a focus on cardiovascular medications such as Doxazosin. The company has a strong presence in the local market and exports its products to several countries in Europe and Asia.

4. Neopharm Group
Neopharm Group is a major pharmaceutical company in Israel, with a diverse portfolio of generic drugs, including Doxazosin. The company’s Doxazosin products are widely used in the treatment of hypertension and benign prostatic hyperplasia, contributing to its success in the market.

5. Rafa Laboratories Ltd.
Rafa Laboratories Ltd. is a well-established pharmaceutical company in Israel, known for its high-quality generic medications, including Doxazosin. The company’s Doxazosin products are popular among healthcare providers and patients alike, driving its growth in the market.

6. Taro Pharmaceuticals Ltd.
Taro Pharmaceuticals Ltd. is a prominent player in the Israeli pharmaceutical industry, specializing in the production of generic drugs like Doxazosin. The company’s Doxazosin products are in high demand due to their efficacy and affordability, leading to strong sales in the market.

7. Dexcel Pharma
Dexcel Pharma is a leading manufacturer of generic medications in Israel, with a focus on cardiovascular drugs such as Doxazosin. The company’s Doxazosin products are widely prescribed by healthcare professionals, contributing to its market success.

8. Unipharm
Unipharm is a well-known pharmaceutical company in Israel, with a history of producing high-quality generic drugs, including Doxazosin. The company’s Doxazosin products are trusted by healthcare providers and patients, driving its sales in the market.

9. Trima Pharmaceuticals
Trima Pharmaceuticals is a key player in the Israeli pharmaceutical industry, specializing in the production of generic medications like Doxazosin. The company’s Doxazosin products are known for their effectiveness and affordability, making them a popular choice among consumers.

10. Ophtechnics Unlimited
Ophtechnics Unlimited is a reputable pharmaceutical company in Israel, with a focus on generic drugs, including Doxazosin. The company’s Doxazosin products are widely used in the treatment of various cardiovascular conditions, driving its success in the market.

Insights:

The market for Doxazosin generics in Israel is poised for continued growth in the coming years, driven by the increasing demand for cost-effective medications. With a focus on quality and affordability, Israeli manufacturers are well-positioned to capitalize on this trend. According to industry forecasts, the market for generic drugs in Israel is expected to grow by 5% annually, reaching a value of $2.5 billion by 2023. As such, manufacturers of Doxazosin generics in Israel are likely to see continued success in the market, both domestically and internationally.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →